Literature DB >> 2033919

Hormone replacement therapy and its influence on AT-III activity in climacteric women.

H Enzelsberger1, G Heytmanek, C Kurz, M Metka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2033919     DOI： 10.1007/bf01646949

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  4 in total

1.  The comparative effects of a synthetic and a 'natural' oestrogen on the haemostatic mechanism in patients with primary amenorrhoea.

Authors:  J L Toy; J A Davies; K W Hancock; G P McNicol
Journal:  Br J Obstet Gynaecol       Date:  1978-05

2.  [Thoughts on long-term estrogen substitution--should gynecologists change their mind?].

Authors:  W Völker; R D Hesch; H P Schneider
Journal:  Geburtshilfe Frauenheilkd       Date:  1985-05       Impact factor: 2.915

3.  At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women.

Authors:  J Conard; B Cazenave; M Samama; M H Horellou; J R Zorn; C Neau
Journal:  Thromb Res       Date:  1980-06-01       Impact factor: 3.944

4.  [Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].

Authors:  R Hesse; W Tritschler; G Castelfranchi; W Bablok
Journal:  Blut       Date:  1981-04
  4 in total
  1 in total

Review 1.  Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

Authors:  R Whittington; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.